EARNINGS & TRADING: Microsalt lowers sales 2026 guidance
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 5.75p on 14-08-2026 at 17:35:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 6.00p |
| Sell | 5.50p |
| Last Trade: | Buy 1,057.00 at 5.85p |
| Day's Volume: | 72,968 |
| Last Close: | 5.75p |
| Open: | 5.75p |
| ISIN: | GB00BP0RTP38 |
| Day's Range | 5.75p - 5.75p |
| 52wk Range: | 4.60p - 13.25p |
| Market Capitalisation: | £5.94m |
| VWAP: | 5.68582p |
| Shares in Issue: | 103.30m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
OptiBiotix Health (OPTI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,057 | 5.85p | Ordinary |
16:02:10 - 14-Aug-26 |
| Buy* | 18,640 | 5.88p | Ordinary |
14:31:44 - 14-Aug-26 |
| Sell* | 17,880 | 5.615p | Ordinary |
14:19:00 - 14-Aug-26 |
| Sell* | 14,327 | 5.615p | Ordinary |
14:06:57 - 14-Aug-26 |
| Sell* | 17,491 | 5.615p | Ordinary |
11:02:19 - 14-Aug-26 |
| Buy* | 83 | 6.00p | Ordinary |
08:32:04 - 14-Aug-26 |
| Sell* | 3,490 | 5.60p | Ordinary |
08:28:24 - 14-Aug-26 |
| Sell* | 938 | 5.60p | Ordinary |
16:06:38 - 13-Aug-26 |
| Sell* | 2,000 | 5.60p | Ordinary |
15:41:27 - 13-Aug-26 |
| Sell* | 20,000 | 5.60p | Ordinary |
14:50:35 - 13-Aug-26 |
OptiBiotix Health (OPTI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jun 2026 3:00 pm | RNS-R | Investor presentation and Q&A |
| 23rd Jun 2026 4:25 pm | RNS | Result of AGM |
| 2nd Jun 2026 7:00 am | RNS-R | Investor presentation and SweetBiotix® Sampling |
| 29th May 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 28th May 2026 7:00 am | RNS | Final Results & Notice of AGM |
| 14th May 2026 7:00 am | RNS-R | SweetBiotix® Sampling |
| 5th May 2026 2:30 pm | RNS | Holding(s) in Company |
| 1st May 2026 12:00 pm | RNS | Partial Disposal of Shares in SkinBioTherapeutics |
| 1st Apr 2026 7:00 am | RNS | Trading Update |
| 24th Feb 2026 7:00 am | RNS | WellBiome® clinical trial on surgical outcomes |